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Noninvasive ventilation in acute respiratory distress syndrome: A long way ahead
Sir, We thank Rao et al. for their observation on our study [1] regarding the use of noninvasive ventilation (NIV) in mild-to-moderate acute respiratory distress syndrome (ARDS). [2] The response from Rao and Munta presents a very gloomy picture for the role of NIV in ARDS, which is not true. [2] The judicious use of NIV has been shown to prevent endotracheal intubation in 52% of the cases of ARDS. [3] The mortality rate in studies involving the use of NIV in ARDS is variable, depending on the patient profile. [3] While it was 32% in the study ( Thille et al.) [4] quoted by Rao et al., it has been reported to be as high as 71%. [5] The authors have raised a concern regarding a delay in intubation being the primary reason for high mortality. They further suggest that earlier intubation could have avoided the deaths in our study. [1] The median (interquartile range) time to intubation was 3 (1-4) h in our study that is far earlier than that reported in an international multicenter study on the use of NIV in ARDS. [6] Further, without a control group of invasive ventilation, one cannot conclude from our study that the use of NIV or delay in intubation led to an increase in mortality. In addition, Rao et al. quote a retrospective study (a study design fraught with many limitations) describing the use of NIV in ARDS following esophagectomy (postsurgical patients), [7] the patient profile being entirely different from that of our study (predominantly sepsis). Interestingly, Rao et al. claim an astonishingly low mortality rate of ARDS in their Intensive Care Unit (ICU) using pressure control ventilation (a strategy yet to establish its role in ARDS). [2] Only two strategies have shown a reduction in mortality in patients with ARDS, namely the low tidal volume strategy using volume control ventilation and prone ventilation. [8, 9] The mortality even at best centers has been reported to be around 32%. [8] Further, the reference by the authors where they suggest a low mortality in their ICU seems to be a review article and not an original article subjected to the rigors of a thorough peer review. [ 
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Unusual manufacturing defect of the endotracheal tube: Problem revisited
Sir, Manufacturing defects of endotracheal tube (ETT) are still encountered in routine anesthesia practice. Many such defects go unnoticed during routine inspection prior to their use. We report a case of manufacturing defect at the junction of pilot balloon and spring-loaded one-way valve in a prepacked, single use, cuffed ETT. This case highlights the significance of standard monitoring of ventilation and the role of a vigilant clinician in detecting such defects and avoiding critical events that can arise from the use of such defective ETTs. It also emphasizes the need for double-checking ETT prior to their use. Difficulty in ventilating a tracheally intubated patient as a result of ETT defect is known in anesthesia practice. Despite the common practice of visual inspection and testing of ETTs for physical defects prior to use, some manufacturing defects still go unnoticed. [1] The patient, 8-year-old female weighing 24 kg, posted for fistulectomy for internal fistula of the left eye under general anesthesia. Her trachea was intubated with a 6.0 mm ID cuffed ETT and was ventilated with tidal volume (Vt) of 200 ml with a rate of 15/min. The correct placement of the tube was ensured and after three to four machine delivered breaths exhaled Vt started decreasing by more than 60 ml at around 20 cm H 2 O of cuff pressure. The tube in question is a CE-certified product (Hansraj Nayyar, Mumbai, India). We initially thought that the cuff needs to be inflated but in spite of inflating it the exhaled Vt would increase but only to decrease after a few breaths. When the leak was significant and end-tidal carbon dioxide started building up, we removed the tube and inserted a new tube, and thereafter ventilation was satisfactory. When we inserted the cuff of the tube in a bowl of water to check its potency, we did not find any leak, but the cuff was not sustaining the pressure to which it was inflated as measured by the cuff manometer. To our surprise, when we dipped both the pilot balloon and the cuff, the leak was detected at the junction of spring-loaded one-way 
